Human GeneticsGenetic & Genomic MedicinePeer-reviewed journal article
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity.
Chiara FalleriniiD, Nicola PicchiottiiD, Margherita BaldassarriiD, Kristina ZguroiD, Sergio DagaiD, Francesca FavaiD, Elisa BenettiiD, Sara AmitranoiD, Mirella BruttiniiD, Maria PalmieriiD, Susanna CrociiD, Mirjam Lista, Giada BeligniiD, Floriana Valentino, Ilaria MeloniiD, Marco TanfoniiD, Francesca MinnaiiD, Francesca ColomboiD, Enrico CabriiD, Maddalena FratelliiD, Chiara GabbiiD, Stefania MantovaniiD, Elisa FrullantiiD, Marco GoriiD, Francis P. CrawleyiD, , Pier Giorgio Scotton
Abstract
The combined impact of common and rare exonic variants in COVID-19 host genetics is currently insufficiently understood. Here, common and rare variants from whole exome sequencing data of about 4,000 SARS-CoV-2-positive individuals were used to define an interpretable machine learning model for predicting COVID-19 severity. Firstly, variants were converted into separate sets of Boolean features, depending on the absence or the presence of variants in each gene. An ensemble of LASSO logistic regression models was used to identify the most informative Boolean features with respect to the genetic bases of severity. The Boolean features selected by these logistic models were combined into an Integrated PolyGenic Score that offers a synthetic and interpretable index for describing the contribution of host genetics in COVID-19 severity, as demonstrated through testing in several independent cohorts. Selected features belong to ultra-rare, rare, low-frequency, and common variants, including those in linkage disequilibrium with known GWAS loci. Noteworthly, around one quarter of the selected genes are sex-specific. Pathway analysis of the selected genes associated with COVID-19 severity reflected the multi-organ nature of the disease. The proposed model might provide useful information for developing diagnostics and therapeutics, while also being able to guide bedside disease management.
- organism: human
- assay: whole-exome sequencing
- research focus: differential expression
- approach: machine learning (classical)
- Citations
- 37
- FWCI
- 4.10
- Field percentile
- top 5%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Host genetics and COVID-19 severity: increasing the accuracy of latest severity scores by Boolean quantum features
Gabriele Martelloni, Alessio Turchi, … Alessandra Renieri·Frontiers in GeneticsPeer-reviewed·May 22, 2024
- Post-Mendelian genetic model in COVID-19
Nicola Picchiotti, Elisa Benetti, … Simone Furini·Cardiology and Cardiovascular MedicinePeer-reviewed·Jan 1, 2021
- A comprehensive knowledgebase of known and predicted human genetic variants associated with COVID-19 susceptibility and severity
Meltem Ece Kars, David F. Stein, … Yuval Itan·Clinical ImmunologyPeer-reviewed·May 1, 2023
- Common and rare variant analyses combined with single-cell multiomics reveal cell-type-specific molecular mechanisms of COVID-19 severity
Sai Zhang, Johnathan Cooper‐Knock, … Michael P. Snyder·Cell SystemsPeer-reviewed·Jun 3, 2022
- Genetic determinants of severe COVID-19 in young Asian and Middle Eastern patients
Beshr Abdulaziz Badla, Mohamed Samer Hanifa, … Ahmad N. Abou Tayoun·medRxiv·Jan 11, 2023
- Evaluation of a genetic risk score for severity of COVID-19 using human chromosomal-scale length variation.
Christopher Toh, James P. Brody·Human GenomicsPeer-reviewed·Oct 9, 2020